South Florida Enhanced Track

ACO Name and Location

Orange Accountable Care Organization of South Florida LLC
Previous Names: N/A
14750 NW 77th Court
Suite 308
Miami Lakes, FL 33016

 

ACO Primary Contact

Primary Contact Name	Lissette Exposito RN, BSN, MHSA, Founder and President
Primary Contact Phone Number	(786) 363-8500
Primary Contact Email Address	Lissette.Exposito@orangecaregroup.com

 

Organizational Information

ACO Participants:

ACO Participants	ACO Participant in Joint Venture
ADVANCED MEDICAL CARE ASSOCIATES PA	N
Ageless Medicine Associates Inc.	N
ANA ELOSEGUI	N
BERNARD WEINBACH MD PA	N
BROWARD MEDICAL ASSOCIATES OF SOUTH FLORIDA	N
CARDIOLOGY CONSULTANTS OF WEST BROWARD,PA	N
CHANDRAKANT SHAH MD PA	N
Charles Yanes, M.D., P.A.	N
COOPER FAMILY MEDICAL PLLC	N
EAST FLORIDA PREMIUM MEDICAL CARE LLC	N
ELIAS A M FEANNY MD PA	N
FARID MARQUEZ MD PA	N
FRANCISCO ADELQUIS CRUZ MDPA	N
GABRIEL M DESCHAMPS MD PA	N
GERARDO QUINONEZ, M.D., P.A.	N
GUS ARMENAKIS MD PA	N
HECTOR M DELGADO D O P A	N
IVAN ESPAILLAT MD PA	N
JEFFREY GREIFF	N
JEFFREY L PRESSER MD PA	N
JOSE GONZALEZ	N
LAWRENCE A BERGER MD PA	N
LAZARO VIGOA MD PA	N
LEVINSON AND CARDENAS, PA	N
LILI ESTRIN MD, PA	N
LUIS E DE ARMAS MD CORP	N
MARTIN DAYTON DO PA	N
MIAMI CENTER FOR ADVANCED CARDIOLOGY LLC	N
MICHAEL D FELDMAN DO PA	N
MICHAEL J BRAUN MD LLC	N
Milton A. Jimenez MD PA	N
MIREL SANCHEZ, M.D., P.A.	N
MY PERSONAL MD, LLC	N
OSCAR MENDEZ MD PA	N
OTTO L SECADA MD PA	N
PATRICIA BRAVO MD PA	N
PAZ ALVAREZ LLC	N
PEDRO G. ALVAREZ, D.O., P.A.	N
PEDRO ORLANDO DIAZ MD PA	N
QUALCARE MEDICAL GROUP INC	N
ROBERTO URQUIZA M D P A	N
ROMEO E ROJAS MD PA	N
SOFFER HEART INSTITUTE PA	N
SOHAIL DELFANI MD P.A.	N
SOUTH FLORIDA INTERNISTS GROUP PA	N
SUSSMAN & STALLER MD PA	N
VINCENT C CHIN M.D., P.A.	N

 

ACO Governing Body:

Member First Name	Member Last Name	Member Title/Position	Member’s Voting Power (Expressed as a percentage)	Membership Type	ACO Participant Legal Business Name, if applicable
Exposito	Lissette	President, CEO & Board Chair	24%	Board Chair and Voting Member
Quintela, MD	Pablo	CMIO & Board Member	0%	Board Advisor
Weinbach, MD	Bernard	Medical Director & Board Member	18.75%	ACO Participant & Voting Member	BERNARD WEINBACH MD PA
Sanchez, MD	Mirel	Board Member	18.75%	ACO Participant & Voting Member	MIREL SANCHEZ, M.D., P.A.
Presser, MD	Jeffrey	Board Member	18.75%	ACO Participant & Voting Member	JEFFREY L PRESSER MD PA
Cooper, MD	Catherine	Board Member	18.75%	ACO Participant & Voting Member	COOPER FAMILY MEDICAL PLLC
Oliver	Mara	Board Member	1%	ACO Patient and Medicare Beneficiary Representative

 

Key ACO Clinical and Administrative Leadership:

• ACO Executive: Lissette Exposito
• Medical Director: Pablo Quintela
• Compliance Officer: Marc Troisi
• Quality Assurance/Improvement Officer: Michael Labinski

 

Associated Committees and Committee Leadership:

 

Committee Name	Committee Leader Name and Position
Quality and Informatics	Pablo Quintela, MD, Chair
Patient Experience	Raphael Ruiz, Chair
Finance and Contracting	Frank Exposito, Co-Chair Pablo Quintela, MD, Co-Chair

 

Types of ACO Participants, or Combinations of Participants, That Formed the ACO:

• ACO professionals in a group practice arrangement
• Networks of individual practices of ACO professionals

 

Shared Savings and Losses

Amount of Shared Savings/Losses:

• Second Agreement Period
  • Performance Year 2021, $13,112,590
• First Agreement Period
  • Performance Year 2020, $16,161,631
  • Performance Year 2019, $6,692,187
  • Performance Year 2018, $3,172,313
  • Performance Year 2017, $2,643,135

Shared Savings Distribution:

• Second Agreement Period
  • Performance Year 2021
    • Proportion invested in infrastructure: 20%
    • Proportion invested in redesigned care processes/resources: 20%
    • Proportion of distribution to ACO participants: 60%
  • First Agreement Period
    • Performance Year 2020
      • Proportion invested in infrastructure: 20%
      • Proportion invested in redesigned care processes/resources: 20%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2019
      • Proportion invested in infrastructure: 20%
      • Proportion invested in redesigned care processes/resources: 20%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2018
      • Proportion invested in infrastructure: 20%
      • Proportion invested in redesigned care processes/resources: 20%
      • Proportion of distribution to ACO participants: 60%
    • Performance Year 2017
      • Proportion invested in infrastructure: 20%
      • Proportion invested in redesigned care processes/resources: 20%
      • Proportion of distribution to ACO participants: 60%

 

Quality Performance Results

2021 Quality Performance Results:

Quality performance results are based on CMS Web Interface

 

Measure #	Measure Name	Rate	ACO Mean
001	Diabetes: Hemoglobin A1c (HbA1c) Poor Control2	10.75	12.46
134	Preventative Care and Screening: Screening for Depression and Follow-up Plan	80.89	74.38
236	Controlling High Blood Pressure	84.32	74.87
318	Falls: Screening for Future Fall Risk	91.55	87.03
110	Preventative Care and Screening: Influenza Immunization	83.92	80.52
226	Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention	94.74	80.97
113	Colorectal Cancer Screening	91.19	73.63
112	Breast Cancer Screening	83.57	75.11
438	Statin Therapy for the Prevention and Treatment of Cardiovascular Disease	85.23	84.24
370	Depression Remission at Twelve Months	12.50	15.50
321	CAHPS for MIPS3	N/A	N/A
479	Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups2	0.1645	0.1540
MCC1	All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions for ACOs (MCC)2	30.49	33.99

 

For previous years’ Financial and Quality Performance Results, please visit: data.cms.gov

 

Payment Rule Waivers

• Skilled Nursing Facility (SNF) 3-Day Rule Waiver:
  • Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR § 425.612.